Aries Wealth Management Zoetis Inc. Transaction History

Aries Wealth Management

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 10, 2024	BUY	$151.44 - $200.09 $174,610 - $230,703	1,153 New	1,153 $227,000
Q2 2023 Jul 13, 2023	BUY	$160.94 - $186.23 $191,196 - $221,241	1,188 New	1,188 $204,000
Q3 2022 Nov 02, 2022	BUY	$148.29 - $182.55 $205,826 - $253,379	1,388 New	1,388 $209,000
Q1 2022 Apr 25, 2022	SELL	$181.39 - $234.03 $188,282 - $242,923	-1,038 Closed	0 $0
Q4 2021 Jun 06, 2022	SELL	$193.69 - $247.03 $1.21 Million - $1.54 Million	-6,228 Reduced 85.71%	1,038 $253,000
Q4 2021 Jan 18, 2022	BUY	$193.69 - $247.03 $1.21 Million - $1.54 Million	6,228 Added 600.0%	7,266 $1.77 Million
Q3 2021 Oct 13, 2021	SELL	$189.29 - $209.69 $15,900 - $17,613	-84 Reduced 7.49%	1,038 $202,000
Q2 2021 Jul 14, 2021	BUY	$155.9 - $187.99 $174,919 - $210,924	1,122 New	1,122 $209,000

1,957

412M

1.02M

1.09M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $82B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of Aries Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Aries Wealth Management with notifications on news.